NO20005410L - Fremgangsmåte for fremstilling av metyl(2S)-2((3R)-3-(N-(tert- butyloksykarbamyl)-amino)-2-oksopyrrolidin-1-yl)propionat - Google Patents
Fremgangsmåte for fremstilling av metyl(2S)-2((3R)-3-(N-(tert- butyloksykarbamyl)-amino)-2-oksopyrrolidin-1-yl)propionatInfo
- Publication number
- NO20005410L NO20005410L NO20005410A NO20005410A NO20005410L NO 20005410 L NO20005410 L NO 20005410L NO 20005410 A NO20005410 A NO 20005410A NO 20005410 A NO20005410 A NO 20005410A NO 20005410 L NO20005410 L NO 20005410L
- Authority
- NO
- Norway
- Prior art keywords
- oxopyrrolidin
- propionate
- tert
- amino
- methyl
- Prior art date
Links
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 title abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title abstract 2
- -1 (3R) -3- (N- (tert-butyloxycarbamyl) amino) -2-oxopyrrolidin-1-yl Chemical group 0.000 title 1
- 238000001311 chemical methods and process Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809021.0A GB9809021D0 (en) | 1998-04-29 | 1998-04-29 | Chemical process |
| PCT/GB1999/001307 WO1999055669A1 (en) | 1998-04-29 | 1999-04-27 | Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yl]propionate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005410D0 NO20005410D0 (no) | 2000-10-27 |
| NO20005410L true NO20005410L (no) | 2000-12-21 |
Family
ID=10831089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005410A NO20005410L (no) | 1998-04-29 | 2000-10-27 | Fremgangsmåte for fremstilling av metyl(2S)-2((3R)-3-(N-(tert- butyloksykarbamyl)-amino)-2-oksopyrrolidin-1-yl)propionat |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6248903B1 (no) |
| EP (1) | EP1076645B1 (no) |
| JP (1) | JP2002513000A (no) |
| KR (1) | KR20010043046A (no) |
| CN (1) | CN1298387A (no) |
| AT (1) | ATE260892T1 (no) |
| AU (1) | AU3719199A (no) |
| BR (1) | BR9910014A (no) |
| CA (1) | CA2327363A1 (no) |
| DE (1) | DE69915274T2 (no) |
| GB (1) | GB9809021D0 (no) |
| IL (1) | IL139310A0 (no) |
| NO (1) | NO20005410L (no) |
| NZ (1) | NZ506954A (no) |
| WO (1) | WO1999055669A1 (no) |
| ZA (1) | ZA200005302B (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130285D0 (en) | 2001-12-19 | 2002-02-06 | Astrazeneca Ab | Chemical process |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3723534A (en) | 1971-05-28 | 1973-03-27 | Monsanto Co | Aryl methyl phenacyl sulfonium tetrafluoroborates |
| US4377515A (en) | 1979-10-01 | 1983-03-22 | Merck & Co., Inc. | Long lasting agonists and antagonists of LH-RH |
| AU7604196A (en) | 1995-10-30 | 1997-05-22 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
| GB9702377D0 (en) | 1996-02-23 | 1997-03-26 | Zeneca Ltd | Peptide derivatives |
| BR9709533A (pt) | 1996-06-07 | 1999-08-10 | Zeneca Ltd | Derivado de peptídeo uso e processo para a produção do mesmo composição farmacéutica processo para o tratamento de uma doença autoimune ou inflamatória mediada por célula t dependente de mhc classe ii e aminoácido protegido ou desprotegido ou um sal do mesmo |
| GB9624562D0 (en) | 1996-11-27 | 1997-01-15 | Zeneca Ltd | Peptide derivatives |
-
1998
- 1998-04-29 GB GBGB9809021.0A patent/GB9809021D0/en not_active Ceased
-
1999
- 1999-04-27 EP EP99919389A patent/EP1076645B1/en not_active Expired - Lifetime
- 1999-04-27 KR KR1020007011912A patent/KR20010043046A/ko not_active Withdrawn
- 1999-04-27 AT AT99919389T patent/ATE260892T1/de not_active IP Right Cessation
- 1999-04-27 JP JP2000545830A patent/JP2002513000A/ja active Pending
- 1999-04-27 CN CN99805524A patent/CN1298387A/zh active Pending
- 1999-04-27 US US09/674,085 patent/US6248903B1/en not_active Expired - Fee Related
- 1999-04-27 AU AU37191/99A patent/AU3719199A/en not_active Abandoned
- 1999-04-27 WO PCT/GB1999/001307 patent/WO1999055669A1/en not_active Application Discontinuation
- 1999-04-27 BR BR9910014-2A patent/BR9910014A/pt not_active IP Right Cessation
- 1999-04-27 IL IL13931099A patent/IL139310A0/xx unknown
- 1999-04-27 NZ NZ506954A patent/NZ506954A/xx unknown
- 1999-04-27 DE DE69915274T patent/DE69915274T2/de not_active Expired - Fee Related
- 1999-04-27 CA CA002327363A patent/CA2327363A1/en not_active Abandoned
-
2000
- 2000-09-29 ZA ZA200005302A patent/ZA200005302B/en unknown
- 2000-10-27 NO NO20005410A patent/NO20005410L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB9809021D0 (en) | 1998-06-24 |
| NZ506954A (en) | 2003-06-30 |
| ATE260892T1 (de) | 2004-03-15 |
| AU3719199A (en) | 1999-11-16 |
| JP2002513000A (ja) | 2002-05-08 |
| KR20010043046A (ko) | 2001-05-25 |
| WO1999055669A1 (en) | 1999-11-04 |
| CN1298387A (zh) | 2001-06-06 |
| BR9910014A (pt) | 2001-01-09 |
| US6248903B1 (en) | 2001-06-19 |
| CA2327363A1 (en) | 1999-11-04 |
| DE69915274D1 (de) | 2004-04-08 |
| DE69915274T2 (de) | 2005-02-24 |
| EP1076645A1 (en) | 2001-02-21 |
| NO20005410D0 (no) | 2000-10-27 |
| ZA200005302B (en) | 2001-10-01 |
| EP1076645B1 (en) | 2004-03-03 |
| IL139310A0 (en) | 2001-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1353917T3 (da) | Ny fremgangsmåde til syntesen af 5-(4-fluorphenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrol-3-carboxylsyre phenylamid | |
| ID28070A (id) | Kalsium (3s) tetrahidro-3-furanil (1s,2r)-3-((4-aminofenil) sulfonil) (isobutil) amino)-1-benzil-2-(fosfonooksi) propilkarbamat | |
| BR9806060B1 (pt) | composto n-[(aminoiminometil ou aminometil) fenil] propil amida, e, composição farmacêutica. | |
| MXPA03005219A (es) | Peptidos diarilicos como inhibidores de ns3-serina proteasa en hepatitis de virus c. | |
| ATE241998T1 (de) | Multikatalytische protease-inhibitoren | |
| GB2382346A (en) | Method of synthesizing diketopiperazines | |
| HU9603237D0 (en) | Kristalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane | |
| AP9901462A0 (en) | Stable non-hygroscopic crystalline form of N-[N-N-(4-(Piperidin-4-YL)Butanoyl)-N-Ethylglycyl] amide. | |
| NO20016151L (no) | Fremstilling av substituerte piperidin-4-oner | |
| HUP9802586A2 (hu) | A (-)-[2-(2-tienil)-etilamino]-(2-halogénfenil)-acetamidok racemizálási eljárása | |
| BG103751A (bg) | Метод за получаване на междинни съединения за синтез на пестициди | |
| NO20005410D0 (no) | FremgangsmÕte for fremstilling av metyl(2S)-2((3R)-3-(N-(tert- butyloksykarbamyl)-amino)-2-oksopyrrolidin-1-yl)propionat | |
| BG103197A (bg) | Антитромботични азациклоалкилалканоил пептиди и псевдопептиди | |
| BG104243A (en) | Method for the synthesis of quinoline derivatives | |
| AU4300497A (en) | Process for the manufacture of aliphatic alpha, omega amino nitriles | |
| ZA99939B (en) | Process for the preparation of 2-aryl-5-(perfluoroalkyl) pyrrole compounds from N-(perfluoroalkylmethyl) arylimidoyl chloride compounds. | |
| DK1257557T3 (da) | Fremgangsmåde til fremstilling af N-(phosphonomethyl)glycin | |
| ID21499A (id) | Proses untuk memproduksi n-(4-fluorofenil)-n-(1-metiletil)-2-[(5-(trifluorometil)-1,3,4-tiadiazol-2-il)-oksi]-asetamida | |
| BR9908970A (pt) | Processo para a preparação do composto, e, composto | |
| IT1295311B1 (it) | Processo industriale per la sintesi di ammino acetileni | |
| DK1313712T3 (da) | Fremgangsmåde og mellemforbindelser til fremstilling af retrovirale proteaseinhibitorer | |
| ES2177980T3 (es) | Procedimiento para la preparacion de un tiazol disustituido. | |
| NO20002944D0 (no) | FremgangsmÕte for fremstilling av isopropylmetyl-(2-)3-n- propolsyfenoksy)etyl)amin | |
| YU38000A (sh) | Novi procesi i međuproizvodi | |
| DK1551863T3 (da) | Fremgangsmåde til syntese af peptider, der omfatter mindst ét glycinmolekyle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |